The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
Highlights Mirvetuximab-based regimen promise
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Subscribe To Our Newsletter & Stay Updated
